tripalmitin has been researched along with acetylcysteine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, K; Haack, D; Kienberger, D; Köberle, M; Lochmann, D; Lopes, D; Salar-Behzadi, S; Saurugger, EM; Stehr, M; Zimmer, A | 1 |
Becker, K; Hate, S; Hohl, R; Sacher, S; Salar-Behzadi, S; Schiemenz, W; Stocker, E; Zimmer, A | 1 |
Becker, K; Haack, D; Koutsamanis, I; Laggner, P; Lopes, DG; Salar-Behzadi, S; Scheibelhofer, O; Stehr, M; Zimmer, A | 1 |
3 other study(ies) available for tripalmitin and acetylcysteine
Article | Year |
---|---|
Advanced stable lipid-based formulations for a patient-centric product design.
Topics: Acetylcysteine; Adult; Chemistry, Pharmaceutical; Computer Simulation; Drug Liberation; Drug Stability; Excipients; Female; Humans; Male; Middle Aged; Particle Size; Polysorbates; Solubility; Taste; Technology, Pharmaceutical; Triglycerides; Young Adult | 2016 |
Application of ICH Q9 Quality Risk Management Tools for Advanced Development of Hot Melt Coated Multiparticulate Systems.
Topics: Acetylcysteine; Administration, Oral; Antiviral Agents; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Free Radical Scavengers; Freezing; Particle Size; Polysorbates; Solubility; Spectrophotometry, Infrared; Triglycerides | 2017 |
Microphase separation in solid lipid dosage forms as the cause of drug release instability.
Topics: Acetylcysteine; Crystallization; Drug Compounding; Drug Liberation; Drug Stability; Excipients; Lipids; Particle Size; Phase Transition; Polysorbates; Triglycerides | 2017 |